# FDA Inspection 1169025 - HCSC Blood Center - April 27, 2022

Source: https://www.keypedia.com/records/fda_inspections/hcsc-blood-center/91aa3bb3-a8e5-4fd2-993a-d9555ecaf433
Source feed: FDA_Inspections

> FDA Inspection 1169025 for HCSC Blood Center on April 27, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1169025
- Company Name: HCSC Blood Center
- Inspection Date: 2022-04-27
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1310508 - 2026-03-23](https://www.keypedia.com/records/fda_inspections/hcsc-blood-center/82d334b3-1df8-493e-be05-7b446323fce9)
- [FDA Inspection 1310508 - 2026-03-23](https://www.keypedia.com/records/fda_inspections/hcsc-blood-center/375f285f-f241-4f57-8ba5-c7d5ec8c2d12)
- [FDA Inspection 1169025 - 2022-04-27](https://www.keypedia.com/records/fda_inspections/hcsc-blood-center/970ad4ea-09a7-4289-ac91-6ab672a3ed8c)
- [FDA Inspection 1079965 - 2019-01-24](https://www.keypedia.com/records/fda_inspections/hcsc-blood-center/1b0230aa-f5df-4e47-8c85-8dbb8b12dad9)
- [FDA Inspection 1030585 - 2017-10-19](https://www.keypedia.com/records/fda_inspections/hcsc-blood-center/12277aec-382a-4f72-878b-3ad556540d39)

Company: https://www.keypedia.com/companies/hcsc-blood-center/01847ee3-82da-46e6-b721-9f925d0cc87a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d